Tracking children’s immune response after routine vaccinations
Treatments studied
This study measures how a child’s immune system responds after standard childhood vaccines, like DTaP-IPV/Hib, pneumococcal, MMR, varicella, flu, and COVID shots. It may help researchers better understand what a “healthy” immune response looks like after vaccination.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child’s age must match one of these vaccine timepoints: 5–7 months, 10–18 months, 4–6 years, or they’re getting an annual flu/COVID vaccine
- They must be receiving their scheduled vaccine dose (not an extra dose for a special reason)
- They should not have a history of autoimmune or autoinflammatory disease
- They should not have a history of certain long-term conditions like genetic/metabolic disorders, blood disorders, or cancer
- They should not have signs of a serious infection at the first study visit
- They must meet the minimum weight needed for their study group
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study gives you a flu vaccine and measures how your immune system reacts, including both “blood immunity” and “cell immunity.” It’s for healthy adults and mainly aims to better understand how well flu vaccines work in people without major health issues.
This trial studies how your immune system responds after a COVID-19 vaccine. It uses detailed blood tests to understand what changes happen in your immune cells and may help researchers improve future vaccines.
This study takes small blood samples to learn how the immune system works in healthy people. It may help researchers better understand immune biology for future treatments, while you help by participating in regular research blood draws.
This study looks at how babies’ immune systems develop in early life and how they respond to immunization. It compares preterm infants with full-term infants whose mothers received Tdap during pregnancy, to learn what protection and immune responses to expect.
This trial tests a new vaccine (LR20062) to see how well it protects healthy babies against several diseases. Your baby would receive the vaccine at their 2-month, 4-month, and 6-month checkups.
This study tests a combined vaccine for six diseases in infants 6-11 weeks old. It aims to check if the vaccine is safe and helps babies build protection against diphtheria, tetanus, whooping cough, hepatitis B, Hib, and polio.
Hear when a new Healthy Controls trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.